QUINTARELLI, CONCETTA
QUINTARELLI, CONCETTA
DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA
Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia.
2013 Quintarelli, Concetta; DE ANGELIS, Biagio; Errichiello, S; Caruso, S; Esposito, N; Colavita, I; Raia, M; Pagliuca, S; Pugliese, N; Risitano, ANTONIO MARIA; Picardi, Marco; Luciano, L; Saglio, G; Martinelli, G; Pane, Fabrizio
Generation of Epstein Barr Virus Specific Cytotoxic T Lymphocytes (EBV-CTLs) Resistant to the Immunosuppressive Drug Tacrolimus (FK506)
2009 DE ANGELIS, Biagio; G., Dotti; Quintarelli, Concetta; Le, Huye; L., Zhang; M., Zhang; Heslop, H. E.; Brenner, M. K.; Rooney, C. M.; B. S. a. v. o. l. d., O.
Gene transfer of IL-7R alpha (IL-7R alpha) on antigen-specific cytotoxic T cells (CTLs) restores their ability to respond to IL-7 cytokine
2007 Vera, J. F.; Hoyos, V.; Savoldo, B.; Quintarelli, Concetta; Giordano Attianese, G.; Foster, A. E.; Dotti, G.
Analysis of Bone Marrow Microenviroment Factors As Early Markers of Response in Patients with Newly Diagnosed Bcr-Abl Positive CML in Chronic Phase Treated with Nilotinib.
2012 Quintarelli, Concetta; DE ANGELIS, Biagio; Errichiello, Santa; S., Caruso; N., Esposito; L., Luciano; S., Paratore; C., Galimberti; S., Soverini; C., Terragna; D., Cilloni; G., Saglio; G., Martinelli; F., Giles; A., Hochhaus; Pane, Fabrizio
Safely Improving the in Vivo Survival of Tumor Specific Cytotoxic T Lymphocytes by Co-Transfer of IL7 Receptor Alpha Chain and icaspase9
2008 Vera, J. V.; Hoyos, V.; Savoldo, B.; Quintarelli, Concetta
Transgenic expression of inducible caspase9 suicide gene for in vivo elimination of antigen specific cytotoxic T cells (CTLs) engineered to produce cytokines.
2006 Quintarelli, Concetta; Vera, F. V.; Savoldo, B.; B. Giordano, G.; Brenner, M. K.; Dotti, G.
Reduced Expression Level of SHP1 Gives An Additive Survival Advantage to the Ph plus Cells of Chronic Myeloid Leukemia (CML) Patients and Provides a Novel Pretreatment Predictor of Major Molecular Response Achievement in CML Patients
2009 Esposito, N.; Quintarelli, Concetta; Colavita, I.; Pane, Fabrizio
Transition index: new original tool to identify subsets overlapping MPN phenotypes.
2011 Marano, L; Gherghi, Marco; Pugliese, N; Madonna, E; Quintarelli, Concetta; Ciancia, R; Ciancia, G; Izzo, Barbara; Muccioli Casadei, G; Martinelli, V; Pane, Fabrizio
Induction of PRAME-specific immunity by overlapping pentadecapeptides in patients with hematologic malignancies
2009 Quintarelli, Concetta; DE ANGELIS, Biagio; G., Dotti; L., Luciano; H., Heslop; C., Rooney; M., Brenner; B., Savoldo; Pane, Fabrizio
Early detection of residual disease by Q-RT-PCR of the hybrid BCR/ABL transcript is a powerful predictor of treatment response in adult Philadelphia - Positive acute lymphoblastic leukemia.
2003 Pane, Fabrizio; Izzo, Barbara; Quintarelli, Concetta; Camera, A.; Cimino, G.; Vitale, A.; Specchia, G.; Saglio, G.; Foa, R.; Salvatore, F.; Rotoli, B.; Mandelli, F.
Co-Expression of a Chimeric Antigen Receptor Targeting CD19 (CAR19), Optimized Human IL-15, and iCaspase9 To Enhance the Activity and Safety of Cytotoxic T Lymphocytes
2009 V., Hoyos; B., Savoldo; Vera, J. F.; Quintarelli, Concetta; H., Heslop; Rooney, C. M.; Brenner, M. K.; G., Dotti
Transgenic expression of IL15 selectively expands antigen specific cytotoxic T cells (CTLs) enhancing their anti-tumor effect in vivo.
2006 Quintarelli, Concetta; Savoldo, B.; Giordano, G.; Foster, A.; Pule, M.; Heslop, H.; Rooney, C.; Brenner, M.; Dotti, G.
Preferentially expressed antigen of melanoma (PRAME)-specific cytotoxic T-Lymphocytes (CTLs) and transgenic T cells to target chronic myelogenous leukemia (CML)
2007 Quintarelli, Concetta; . Dotti G, .; De Angelis, B.; Pane, Fabrizio; Savoldo, B.
BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations.
2002 Pane, Fabrizio; Intrieri, M.; Quintarelli, Concetta; Izzo, Barbara; Muccioli, G. C.; Salvatore, F.
Decitabine up-regulates the expression of the cancer-associate prame antigen in early chronic phase CML cells.
2003 Pane, Fabrizio; Quintarelli, Concetta; Izzo, Barbara; Martinelli, G.; Intrieri, M.; Luciano, L.; Amabile, M.; Rosti, G.; Saglio, G.; Baccarani, M.; Salvatore, F.
Hepatitis B virus reactivation after fludarabine-based regiments for indolent non-Hodgkin’s lymphomas: high prevalence of acquired viral genomic mutations.
2003 Picardi, Marco; F., Pane; Quintarelli, Concetta; A., DE RENZO; A., DEL GIUDICE; B., DE DIVITIIS; M., Persico; R., Ciancia; Salvatore, Francesco; B., Rotoli
Gene therapy to improve function of T cells for adoptive immunotherapy.
2010 Quintarelli, Concetta; B., Savoldo; G. D. o. t. t., I.
Genetic manipulation of tumor-specific cytotoxic T lymphocytes to restore responsiveness to IL-7
2009 Vera, Jf; Hoyos, V; Savoldo, B; Quintarelli, Concetta; Giordano Attianese, G; Leen, Am; Liu, H; Foster, Ae; Heslop, He; Rooney, Cm; Brenner, Mk; Dotti, G.
Spleen is the dark side of essential Thrombocitemia
2011 Pugliese, N; Picardi, Marco; Marano, L; Gherghi, Marco; Izzo, Barbara; Ciancia, R; Ciancia, G; Quintarelli, Concetta; Muccioli Casadei, G; Martinelli, V. Pane F.
Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations.
2003 Picardi, Marco; Pane, Fabrizio; Quintarelli, Concetta; DE RENZO, A; DEL GIUDICE, A; DE DIVITIIS, B; Ciancia, R; Salvatore, F; Rotoli, B.
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia. | 1.1 Articolo in rivista | 2013 | Quintarelli, Concetta; DE ANGELIS, Biagio; Errichiello, S; Caruso, S; Esposito, N; Colavita, I; Raia, M; Pagliuca, S; Pugliese, N; Risitano, ANTONIO MARIA; Picardi, Marco; Luciano, L; Saglio, G; Martinelli, G; Pane, Fabrizio | |
| Generation of Epstein Barr Virus Specific Cytotoxic T Lymphocytes (EBV-CTLs) Resistant to the Immunosuppressive Drug Tacrolimus (FK506) | 1.5 Abstract in rivista | 2009 | DE ANGELIS, Biagio; G., Dotti; Quintarelli, Concetta; Le, Huye; L., Zhang; M., Zhang; Heslop, H. E.; Brenner, M. K.; Rooney, C. M.; B. S. a. v. o. l. d., O. | |
| Gene transfer of IL-7R alpha (IL-7R alpha) on antigen-specific cytotoxic T cells (CTLs) restores their ability to respond to IL-7 cytokine | 1.5 Abstract in rivista | 2007 | Vera, J. F.; Hoyos, V.; Savoldo, B.; Quintarelli, Concetta; Giordano Attianese, G.; Foster, A. E.; Dotti, G. | |
| Analysis of Bone Marrow Microenviroment Factors As Early Markers of Response in Patients with Newly Diagnosed Bcr-Abl Positive CML in Chronic Phase Treated with Nilotinib. | 1.5 Abstract in rivista | 2012 | Quintarelli, Concetta; DE ANGELIS, Biagio; Errichiello, Santa; S., Caruso; N., Esposito; L., Luciano; S., Paratore; C., Galimberti; S., Soverini; C., Terragna; D., Cilloni; G., Saglio; G., Martinelli; F., Giles; A., Hochhaus; Pane, Fabrizio | |
| Safely Improving the in Vivo Survival of Tumor Specific Cytotoxic T Lymphocytes by Co-Transfer of IL7 Receptor Alpha Chain and icaspase9 | 1.5 Abstract in rivista | 2008 | Vera, J. V.; Hoyos, V.; Savoldo, B.; Quintarelli, Concetta | |
| Transgenic expression of inducible caspase9 suicide gene for in vivo elimination of antigen specific cytotoxic T cells (CTLs) engineered to produce cytokines. | 1.5 Abstract in rivista | 2006 | Quintarelli, Concetta; Vera, F. V.; Savoldo, B.; B. Giordano, G.; Brenner, M. K.; Dotti, G. | |
| Reduced Expression Level of SHP1 Gives An Additive Survival Advantage to the Ph plus Cells of Chronic Myeloid Leukemia (CML) Patients and Provides a Novel Pretreatment Predictor of Major Molecular Response Achievement in CML Patients | 1.5 Abstract in rivista | 2009 | Esposito, N.; Quintarelli, Concetta; Colavita, I.; Pane, Fabrizio | |
| Transition index: new original tool to identify subsets overlapping MPN phenotypes. | 4.2 Abstract in Atti di convegno | 2011 | Marano, L; Gherghi, Marco; Pugliese, N; Madonna, E; Quintarelli, Concetta; Ciancia, R; Ciancia, G; Izzo, Barbara; Muccioli Casadei, G; Martinelli, V; Pane, Fabrizio | |
| Induction of PRAME-specific immunity by overlapping pentadecapeptides in patients with hematologic malignancies | 1.5 Abstract in rivista | 2009 | Quintarelli, Concetta; DE ANGELIS, Biagio; G., Dotti; L., Luciano; H., Heslop; C., Rooney; M., Brenner; B., Savoldo; Pane, Fabrizio | |
| Early detection of residual disease by Q-RT-PCR of the hybrid BCR/ABL transcript is a powerful predictor of treatment response in adult Philadelphia - Positive acute lymphoblastic leukemia. | 1.5 Abstract in rivista | 2003 | Pane, Fabrizio; Izzo, Barbara; Quintarelli, Concetta; Camera, A.; Cimino, G.; Vitale, A.; Specchia, G.; Saglio, G.; Foa, R.; Salvatore, F.; Rotoli, B.; Mandelli, F. | |
| Co-Expression of a Chimeric Antigen Receptor Targeting CD19 (CAR19), Optimized Human IL-15, and iCaspase9 To Enhance the Activity and Safety of Cytotoxic T Lymphocytes | 1.5 Abstract in rivista | 2009 | V., Hoyos; B., Savoldo; Vera, J. F.; Quintarelli, Concetta; H., Heslop; Rooney, C. M.; Brenner, M. K.; G., Dotti | |
| Transgenic expression of IL15 selectively expands antigen specific cytotoxic T cells (CTLs) enhancing their anti-tumor effect in vivo. | 1.5 Abstract in rivista | 2006 | Quintarelli, Concetta; Savoldo, B.; Giordano, G.; Foster, A.; Pule, M.; Heslop, H.; Rooney, C.; Brenner, M.; Dotti, G. | |
| Preferentially expressed antigen of melanoma (PRAME)-specific cytotoxic T-Lymphocytes (CTLs) and transgenic T cells to target chronic myelogenous leukemia (CML) | 1.5 Abstract in rivista | 2007 | Quintarelli, Concetta; . Dotti G, .; De Angelis, B.; Pane, Fabrizio; Savoldo, B. | |
| BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations. | 1.1 Articolo in rivista | 2002 | Pane, Fabrizio; Intrieri, M.; Quintarelli, Concetta; Izzo, Barbara; Muccioli, G. C.; Salvatore, F. | |
| Decitabine up-regulates the expression of the cancer-associate prame antigen in early chronic phase CML cells. | 1.5 Abstract in rivista | 2003 | Pane, Fabrizio; Quintarelli, Concetta; Izzo, Barbara; Martinelli, G.; Intrieri, M.; Luciano, L.; Amabile, M.; Rosti, G.; Saglio, G.; Baccarani, M.; Salvatore, F. | |
| Hepatitis B virus reactivation after fludarabine-based regiments for indolent non-Hodgkin’s lymphomas: high prevalence of acquired viral genomic mutations. | 1.1 Articolo in rivista | 2003 | Picardi, Marco; F., Pane; Quintarelli, Concetta; A., DE RENZO; A., DEL GIUDICE; B., DE DIVITIIS; M., Persico; R., Ciancia; Salvatore, Francesco; B., Rotoli | |
| Gene therapy to improve function of T cells for adoptive immunotherapy. | 1.1 Articolo in rivista | 2010 | Quintarelli, Concetta; B., Savoldo; G. D. o. t. t., I. | |
| Genetic manipulation of tumor-specific cytotoxic T lymphocytes to restore responsiveness to IL-7 | 1.1 Articolo in rivista | 2009 | Vera, Jf; Hoyos, V; Savoldo, B; Quintarelli, Concetta; Giordano Attianese, G; Leen, Am; Liu, H; Foster, Ae; Heslop, He; Rooney, Cm; Brenner, Mk; Dotti, G. | |
| Spleen is the dark side of essential Thrombocitemia | 4.2 Abstract in Atti di convegno | 2011 | Pugliese, N; Picardi, Marco; Marano, L; Gherghi, Marco; Izzo, Barbara; Ciancia, R; Ciancia, G; Quintarelli, Concetta; Muccioli Casadei, G; Martinelli, V. Pane F. | |
| Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations. | 1.1 Articolo in rivista | 2003 | Picardi, Marco; Pane, Fabrizio; Quintarelli, Concetta; DE RENZO, A; DEL GIUDICE, A; DE DIVITIIS, B; Ciancia, R; Salvatore, F; Rotoli, B. |